Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

被引：0
作者：
Fernando A. Angarita
Amanda J. Cannell
Albiruni R. Abdul Razak
Brendan C. Dickson
Martin E. Blackstein
机构：
[1] University of Toronto,Division of General Surgery, Department of Surgery
[2] Mount Sinai Hospital,Department of Medical Oncology
[3] Princess Margaret Cancer Centre,Department of Medical Oncology
[4] University Health Network,Department of Medicine
[5] University of Toronto,Department of Pathology and Laboratory Medicine
[6] Mount Sinai Hospital,Department of Laboratory Medicine and Pathobiology
[7] University of Toronto,undefined
来源：
BMC Cancer | / 16卷
关键词：
Overall Survival; Soft Tissue Sarcoma; Partial Remission; Leiomyosarcoma; Liposarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
    Akira Kawai
    Kan Yonemori
    Shunji Takahashi
    Nobuhito Araki
    Takafumi Ueda
    Advances in Therapy, 2017, 34 : 1556 - 1571
  • [22] Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma
    Schoffski, Patrick
    Dumez, Herlinde
    Wolter, Pascal
    Stefan, Cristiana
    Wozniak, Agnieszka
    Jimeno, Jose
    Van Oosterom, Allan T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (09) : 1609 - 1618
  • [23] Trabectedin in advanced soft tissue sarcoma: case series
    Demirci, U.
    Buyukberber, S.
    Yetisyigit, T.
    Dizdar, O.
    Benekli, M.
    Alkis, N.
    Coskun, U.
    JOURNAL OF BUON, 2012, 17 (03): : 591 - 592
  • [24] Soft tissue sarcoma in adolescent and young adult patients: a retrospective study using a nationwide bone and soft tissue tumor registry in Japan
    Fukushima, Takashi
    Ogura, Koichi
    Akiyama, Toru
    Takeshita, Katsushi
    Kawai, Akira
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (07) : 1080 - 1087
  • [25] Real-World Experience of efficacy and safety of trabectedin in patients with soft tissue sarcoma: a bicentric retrospective analysis.
    Chaigneau, Loic
    Jary, Marine
    Nerich, Virginie
    Hervieu, Alice
    Aubry, Sebastien
    Barra, Celine Charon
    Meynard, Guillaume
    Neumann, Florent
    Kalbacher, Elsa
    Isambert, Nicolas
    ONCOLOGY, 2022, : 633 - 644
  • [26] Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma
    de Sande Gonzalez, Luis Miguel
    Martin-Broto, Javier
    Kasper, Bernd
    Blay, Jean-Yves
    Le Cesne, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 957 - 963
  • [27] Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives
    Gordon, Erlinda M.
    Sankhala, K. Kumar
    Chawla, Neal
    Chawla, Sant P.
    ADVANCES IN THERAPY, 2016, 33 (07) : 1055 - 1071
  • [28] Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study
    On, Sercan
    Koksal, Baris
    Arik, Zafer
    Caner, Burcu
    Ercan Uzundal, Duygu
    Yazici, Ozan
    Arslan Benli, Burcu
    Eylemer Mocan, Eda
    Gungor, Can
    Guc, Zeynep Gulsum
    Akay, Seval
    Keskinkilic, Merve
    Dik Avci, Hande
    Karaca Yayla, Burcak
    Cakar, Burcu
    Sanli, Ulus Ali
    CURRENT ONCOLOGY, 2024, 31 (11) : 6803 - 6813
  • [29] Clinical Outcomes After Definitive Treatment of Soft Tissue Sarcoma of the Hand: A Retrospective Cohort Study of 109 Patients
    Chapman, Talia R.
    Lavery, Jessica A.
    Nolan, John E.
    Athanasian, Edward A.
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2024, 49 (09): : 867 - 874
  • [30] The Use of Positron Emission Tomography in Soft Tissue Sarcoma Patients under Therapy with Trabectedin
    Kasper, Bernd
    Schmitt, Thomas
    Wuchter, Patrick
    Dimitrakopoulou-Strauss, Antonia
    Ho, Anthony D.
    Egerer, Gerlinde
    MARINE DRUGS, 2009, 7 (03): : 331 - 340
12345